RPG Life Sciences Limited (RPGLIFE) Share Price & AI Investment Analysis
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenter. Track RPG Life Sciences Limited's live NSE:RPGLIFE share price ₹2,760.20 (-1.65%), market cap ₹₹46B, P/E 38.2. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for RPGLIFE — real-time NSE India stock intelligence.


